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The  type  of  hypersensitiveness  represented by  the  much  studied
tuberculin  allergy  has  been  observed  to occur  in a  number  of  non-
tuberculous infections.  Studies of the altered skin response to soluble
derivatives  or to intact organisms  have been made in infections  due
to  Bacillus typhosus, Bacillus abortus bovinus, Bacillus mallei, Spiro-
cheta pallida, Sporotrichum, and  Trichophyton; and there  are  indica-
tions that the  same phenomenon  may  occur  in other infections.  At
any rate it may be said that allergy to derivatives  of microorganisms
is not an uncommon  accompaniment of  infection.  In a  consideration
of infection  from  the  point of  view  of  allergy,  one of  the questions
which arises is the relation of the tuberculin type of allergy to anaphy-
laxis.  The experiments  of Krause and the  recent work of  Zinsser (1)
indicate  that this type  of  altered  reactivity  is  quite independent  of
anaphylaxis.  They are distinct  phenomena  which  may  or  may  not
coexist  during  an infection.  A  second question  which has long been
under  investigation  and  discussion  is  whether  actual  infection  is
necessary  for  the production  of the  tuberculin type  of allergy.  Stu-
dents  of  tuberculosis  have  until lately  regarded  actual  infection  as
a  necessary  prerequisite  of  tuberculin  and  other  similar  allergies,
although  foci produced by the injection of killed cultures have some-
times been found to be accompanied by a temporary skin allergy.  The
studies of Zinsser (1),  McJunkin  (2),  Petroff  (3),  Lange (4), and Eber-
son (5) have in the last few years cast doubt on the belief that actual
infection  is  necessary.  The  experiments  reported  in this paper  add
additional  evidence  in support of  the idea that an  allergy of  the  tu-
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berculin type  may be produced in the absence of infection.  A  third
question relates to the r6le that allergy plays in the immunity  mecha-
nism.
While  opinion  has  favored  the  view  that  tuberculin  allergy  is  an
important factor in tuberculosis  immunity,  the evidence  is not  com-
plete, and with regard to the r61le of this kind of allergy in the immu-
nity mechanisms of other types of infection, there has been little more
than  analogy  to  support  the  hypothesis  that  its presence  indicates
resistance to infection by the homologous organism.
In  a  separate  paper  (6)  experiments  dealing  with  the' effects  of
anaphylaxis to pneumococcus  protein upon resistance  to pneumococ-
cus  infection  have  been  reported.  The  present  paper  deals  with
the effects,  or  rather,  as will be  shown,  the nearly  complete  absence
of  effects  upon  resistance  to  pneumococcus  infection  of an  allergy
produced with soluble derivatives.  The organism  used in the present
study has been the same  strain  of  Pneumococcus  Type I, with viru-
lence  enhanced  by  repeated passage  through  guinea  pigs,  that  was
described  in the preceding  paper.  The  pneumococcus  protein was
prepared  in  the  same  way.  The  animals  used  were  guinea  pigs
weighing  at  the  beginning  of  each  experiment  200  to  250 gm.
In attempting by several methods  to render guinea pigs  allergic  to
pneumococcus  protein  it  was  found  that  repeated  intracutaneous
injections  (0.02  to 0.05  cc.)  of a solution containing  10 mg. of nitro-
gen  per  100  cc.  yielded  the  most  satisfactory  results.  About  two-
thirds of the animals so treated developed during the 3rd, 4th, or 5th
week  after  the first  injection  a distinct  cutaneous  allergy.  The  cu-
taneous reaction produced in this way develops  after  a latent period
of  8  to  16  hours;  it consists  of  a  firm  bright  red  nodular  elevation
varying, when 0.02  cc. has been injected,  from 6 to 15  mm. in diame-
ter  (Fig.  1).  It  persists  2 or  3  days  and  then  recedes  without
breaking  down.  It  is,  therefore,  in  its  appearance  and  course,
similar  to  a mild tuberculin reaction.  We have not succeeded either
by  the uterus strip  method or  by intravenous  injection  of  the intact
animal in demonstrating  anaphylaxis  in these allergic animals.  This
is in agreement with Zinsser's (1)  observations on the independence  of
tuberculin  allergy  and  tuberculoprotein  anaphylaxis.  When  the
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mococcus  protein was used a  large proportion of the animals died be-
tween the 10th and 20th days.  Presumably such  deaths were  due to
an  immunological  process  since  there  was  no  gross  pathology,  and
post mortem cultures were sterile.  Rosenow  (7) has recorded similar
deaths in using pneumococcus  autolysates for sensitization.
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TExT-FIG.  1. Time  of appearance  and duration  of skin allergy in  a  group of
guinea  pigs  given  repeated  intracutaneous  injections  of  pneumococcus  protein.
The  lines  indicate  the  periods  during  which  allergy  was  demonstrable.  The
arrows  indicate  the  days  on  which  injections  were  given  in amounts of 0,02 to
0.05 cc.  Five of the animals in this experiment  failed to develop  a skin  reaction.
The others showed variations in intensity and duration of the allergy.
Text-fig.  1 records  an experiment  of this  type.  It  is seen that the
skin allergy is manifest during  the 4th and  5th weeks after  the first
injection.  Guinea  pigs  as  purchased  from  dealers  show  important
individual  variations  in  their  susceptibility  to  this  type  of  allergy.
Some  fail to  develop it; others  show  only  slight reaction  for  3 or  4
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days; others have intense reactions during a period of 10 days or more.
As is indicated  in Text-fig.  1, continuance  of  the intracutaneous  in-
jections  after the skin allergy  has developed  results  in a desensitiza-
tion,  so  to speak.  The skin  response  is  no longer  demonstrable.
If  the  resistance  to  the  homologous  pneumococcus  is  titrated  in
a group of guinea  pigs rendered  allergic in this way, it is found that
their susceptibility  to infection differs little or not at all  from  that of
normal controls.  The same absence  of any measurable  alteration in
resistance is found in the animals which have been injected  but  have
failed  to  develop  skin  allergy.  Table  I illustrates  such  a titration.
We have  also found that the animals which have passed through the
phase when  skin allergy is demonstrable  and become desensitized are
likewise  neither  more  nor  less  resistant than normal  controls  to in-
fection with the homologous organism.
The animals  in Groups  I and II  (Table  I)  received  preparatory
intracutaneous  injections  of  pneumococcus  protein  at  intervals  of
2 or 3 days.  After 6  weeks it was found that some animals  had de-
veloped skin allergy  (Group I) and others had not (Group  II).  The
resistance  of  these  two  groups  to  pneumococcus  infection  was  then
tested  by  intraperitoneal  injection  of  the  amounts  shown.  At  the
same  time  normal  controls  (Group  III) were  injected  with  graded
amounts.  From  the table it is seen  that there is very little evidence
that  the animals with skin allergy  to the pneumococcus protein  had
acquired  an  increased  resistance.  Two  of  these  animals  survived
larger  amounts  of  culture  than  sufficed  to kill other  animals.  But
since survivals  of this kind not infrequently  occur in normal animals
injected  with graded  doses we  feel disposed  to attribute  them  more
to individual variations in natural susceptibility than to actively pro-
duced  immunity.  From  our  results,  however,  the  possibility  that
an  occasional  animal  acquired  some  immunity  synchronously  with
the acquisition  of skin allergy  cannot be  completely  excluded.  But
if  such  be  the case,  it is very  irregular  in occurrence  and  slight in
degree.
While our results fail to bring out any evidence  in favor of the idea
that allergy  to pneumococcus  protein is a factor in pneumococcus  im-
munity, there is no valid reason to think that the same relation exists
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between  allergy  and  immunity in other  types  of infection.  As  was
stated  at the beginning  of  this paper,  there  is  sufficient  evidence  to
convince most students  of  tuberculosis  that in  the mechanism  of re-
sistance  to  tubercle  bacillus  infection  allergy  plays  a significant  and
perhaps  predominant  r6le.  And  so  with  other  types  of  infection
allergy may  or may not be  immunologically  important.  Each type
of infection presents  a special  case;  and only  experimental  analysis,
it would  seem,  can  determine whether allergy  is important  or unim-
portant  in  the immunity  mechanism  of  an infection.  No  generali-
zation on the basis of results with the tubercle bacillus or the pneumo-
coccus  is justified.
CONCLUSIONS.
1. Intracutaneous  injection  of  guinea  pigs  with  an  alkaline  ex-
tract of pneumococcus  produces  in  about  two-thirds  of the  animals
an allergy with a skin reaction similar to the allergic skin response of
tuberculosis.
2. Continuance  of the  intracutaneous  injections  after  the  appear-
ance of allergy results in its disappearance.  The skin  ceases to react.
3. Neither  the  animals  manifesting  skin  allergy  nor  those  which
fail  to develop  it show  any significant  alteration  in susceptibility  to
pneumococcus  infection  by  intraperitoneal  inoculation.  Similarly,
animals  desensitized  by  continuing  the  intracutaneous  injections
after  the appearance  of  allergy  show  an unaltered  susceptibility.
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EXPLANATION  OF PLATE  4.
FIG.  1. Skin reaction  produced by the intracutaneous  injection  of  0.02  cc.  of
pneumococcus  protein (N 2 =  10 mg. per 100 cc.)  24 days after the first of a series
of intracutaneous injections.THE JOURNAL  OF EXPERIMENTAL  MEDICINE  VOL.  XLI.
(Mackenzie  and Woo: Cutaneous allergy and pneumococcus  protein.)
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